Exploring Novel Targeted Treatment Strategies for Optimal
Generalized Myasthenia Gravis Care
Podcast #1: Understanding the Potential of FcRn Antagonists
Pre-Test

Questions marked with a * are required
100%
Contact Information
Which of the following best describes the proposed mechanism of action of neonatal Fc receptor (FcRn) antagonists?
Which of the following best describes the proposed mechanism of action of neonatal Fc receptor (FcRn) antagonists?
Which FcRn antagonist is most appropriate to add to the treatment plan of a 15-year-old patient with anti-MuSK-positive gMG, based on its FDA-approved indication?
Which FcRn antagonist is most appropriate to add to the treatment plan of a 15-year-old patient with anti-MuSK-positive gMG, based on its FDA-approved indication?
Which FcRn antagonist is most appropriate to add to the treatment plan of a 30-year-old patient with anti-AChR-positive gMG, based on its FDA-approved indication?
Which FcRn antagonist is most appropriate to add to the treatment plan of a 30-year-old patient with anti-AChR-positive gMG, based on its FDA-approved indication?
Powered by QuestionPro